Preeklampsia dan COVID-19: Literature Review
Abstract
Preeclampsia is a complication in pregnancy which is a hypertensive disorder of pregnancy and develops after the 20th week of pregnancy accompanied by proteinuria as well as being a major cause of maternal and fetal morbidity and mortality in various countries. Apart from preeclampsia, in recent years COVID-19 has also been a contributing cause of maternal morbidity and mortality. COVID-19 is a virus that attacks the respiratory system. This study used a literature review study design. The search for research articles was sourced from the Pubmed electronic database, and the Wiley Online Library with a publication limit of the last 10 years. Search for articles using keywords, namely preeclampsia and COVID-19. The results of a review of the three journals that have been carried out show that when viewed in general and at a glance, preeclampsia and COVID-19 are two different complications, but when viewed from a clinical perspective, preeclampsia and COVID-19 have unique similarities. COVID-19 infection during pregnancy can lead to conditions such as preeclampsia. COVID-19 can cause symptoms that are very similar to preeclampsia, but the symptoms of preeclampsia caused by COVID-19 can disappear completely quickly and these symptoms come on suddenly. If preeclampsia is true, delivery is the way out.
Keywords
Full Text:
PDFReferences
Adeline, M.E., Laksana, M.A.C. and Atika, S. 2018, Characteristic of Referral Patients With Severe Preeclampsia In Surabaya, Biomolecular and Health Science Journal, 1(1), 25.
Anggraini, N.W.P. et al. 2021, Hypoxia Inducible Factor-1-Alpha Expression on Preeclampsia Mice Model With L-Arginine Administration, Folia Medica Indonesiana, 57(3), 226.
Lau SY, Guild SJ, Barrett CJ, et al. 2013, Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in pre-eclamp-sia: a systematic review and meta-analysis. Am J Reprod Immunol. 70(5) 412-427.
Ii, A. et al. 2020, COVID-19 and maternal pre-eclampsia: A synopsis, 9–10..
Luo Y, Yin K. 2020, Management of pregnant women infected with COVID-19. Lancet Infect Dis, 20, 513–14.
Mendoza, M. et al. 2020, Preâ€eclampsiaâ€like syndrome induced by severe Covidâ€19: A prospective observational study, BJOG: An International Journal of Obstetrics & Gynaecology, 127(11), 1374–1380. Available at: https://doi.org/10.1111/1471-0528.16339.
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. 2020, COVID-19: consider cytokine storm syndromes and immunosup-pression. Lancet. 395, 1033-1034
P, W.A., Ernawati, E. and Susanti, D. 2016, Characteristics of Hellp Syndrome in Severe Preeclampsia Patients in Dr. Soetomo Hospital Surabaya, Folia Medica Indonesiana, 51(4), 272.
Pereira A, Cruzâ€Melguizo S, Adrien M, Fuentes L, Marin E, Perezâ€Medina T. 2020, Clinical course of coronavirus diseaseâ€2019 in pregnancy. Acta Obstet Gynecol Scand, 99, 839–847
Thomsn,D., Stang, A. and Owoyemi, I. 2022, Chronic kidney disease and vaccinations–A practical guide for primary care providers, Journal of the National Medical Association, 114(3), S20–S24..
Sathiya, R., Rajendran, J. and Sumathi, S. 2022, Covid-19 and preeclampsia: Overlapping features in pregnancy, Rambam Maimonides Medical Journal, 13(1).
Yesmin F, Islam MS, Ferdoushi S, et al. 2016, Evaluation of serum ferritin concentration in mild and severe pre-eclamptic women. Mymensingh Med J. 25(1), 119-125.
DOI: http://dx.doi.org/10.33087/jiubj.v23i2.3468
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
|